CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Low Dose RadiotherapyWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (1)


Name (Synonyms) Correlation
drug2372 Study Group Wiki 1.00

Correlated MeSH Terms (2)


Name (Synonyms) Correlation
D045169 Severe Acute Respiratory Syndrome NIH 0.05
D018352 Coronavirus Infections NIH 0.04

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Assessment of Adding Low Dose Pulmonary Radiotherapy to the National Protocol of COVID-19 Management: A Pilot Trial

Moderate to severe cases of SARS-associated ARDS based on inclusion/ exclusion criteria and the decision made in multi- disciplinary team are treated with 0.5 Gy whole lung radiation.

NCT04390412 COVID SARS (Severe Acute Respiratory Syndrome) Radiation: Low Dose Radiotherapy
MeSH:Severe Acute Respiratory Syndrome Coronavirus Infections

Primary Outcomes

Description: O2 saturation

Measure: Change from baseline blood oxygenation

Time: 28 days

Description: Total days the patient is admitted to hospital

Measure: Number of Hospital stay days

Time: 28 days

Description: Total days the patient is admitted to ICU

Measure: Number of ICU stay days

Time: 28 days

Description: Total number of intubations performed after the treatment

Measure: Number of intubation events

Time: 28 days

Secondary Outcomes

Description: Changes in WBC count if base-line is abnormal

Measure: WBC

Time: 28 days

Description: Changes in Platelets count if base-line is abnormal

Measure: Platelets

Time: 28 days

Description: Changes in CRP serum level

Measure: CRP

Time: Day 1

Description: Changes in CRP serum level

Measure: CRP

Time: Day 2

Description: Changes in CRP serum level

Measure: CRP

Time: Day 3

Description: Changes in CRP serum level

Measure: CRP

Time: Day 4

Description: Changes in CRP serum level

Measure: CRP

Time: Day 5

Description: Changes in IL-6 serum level

Measure: IL-6

Time: Day 1

Description: Changes in IL-6 serum level

Measure: IL-6

Time: Day 2

Description: Changes in IL-6 serum level

Measure: IL-6

Time: Day 3

Description: Changes in IL-6 serum level

Measure: IL-6

Time: Day 4

Description: Changes in IL-6 serum level

Measure: IL-6

Time: Day 5


No related HPO nodes (Using clinical trials)